<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01621789</url>
  </required_header>
  <id_info>
    <org_study_id>CEP 2146/11</org_study_id>
    <nct_id>NCT01621789</nct_id>
  </id_info>
  <brief_title>Efficacy of Lutein, Zeaxanthine and Trypan Blue to Stain the Anterior Lens Capsule</brief_title>
  <official_title>A Descriptive Study to Evaluate the Efficacy of the Dye Compound of the Combination of Lutein, Zeaxanthin and Trypan Blue to Stain the Anterior Lens Capsule During Cataract Phacoemulsification.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effectiveness of lutein, zeaxanthin and trypan blue to stain the anterior lens capsule during
      cataract phacoemulsification.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty patients with cataract (nuclear, entumecente, total) and indication for cataract
      surgery will be selected to participate in this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visibility of the anterior lens capsule after the injection of dye</measure>
    <time_frame>during the cataract surgery</time_frame>
    <description>The visibility of the anterior lens capsule after the injection of dye, should be graduated as Bad OR Fair OR Good OR Fine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of impregnation of the dye</measure>
    <time_frame>during the surgery</time_frame>
    <description>The degree of impregnation of the anterior lens capsule by the dye should be graduated acording to the following scale:(0)not flushed; (1)stained weakly (light green); (2)moderately stained (medium green); (3)stained intensely (dark green)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>usefulness of the dye</measure>
    <time_frame>at the end of the cataract surgery</time_frame>
    <description>the physician should evaluate the usufelness of the dye, according to the following scale: Bad, Fair, Good, Fine</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>dye of lutein, zeaxanthin, trypan blue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>during the surgery will be evaluated if the dye is suitable for dyeing anterior lens capsule</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>dye of lutein, zeaxanthin, trypan blue</intervention_name>
    <description>dye composed of lutein, zeaxanthin, trypan blue</description>
    <arm_group_label>dye of lutein, zeaxanthin, trypan blue</arm_group_label>
    <other_name>combination of lutein, zeaxanthin, trypan blue</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Patients over 50 years

          -  Diagnosis of cataract (nuclear, entumecente, total)

          -  Absence of red reflex

          -  Indication of cataract surgery

        Exclusion Criteria

          -  Posterior subcapsular cataract

          -  Any history of eye disease

          -  Glaucoma

          -  Eye infection affecting any structure prior ocular

          -  Any previous ocular surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rubens Belfort Jr, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fderal University of São Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Ophthalmology - UNIFESP/Hospital São Paulo</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <zip>04023-062</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Vianna LM, Cohen MJ, Muccioli C, Lima A, Sousa-Martins D, Maia M, Belfort R Jr. Efficacy of a lutein-based dye (Phacodyne™) for visualizing anterior capsulorhexis during cataract surgery by phacoemulsification. Arq Bras Oftalmol. 2014 May-Jun;77(3):173-7.</citation>
    <PMID>25295905</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2012</study_first_submitted>
  <study_first_submitted_qc>June 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2012</study_first_posted>
  <last_update_submitted>March 15, 2016</last_update_submitted>
  <last_update_submitted_qc>March 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Rubens Belfort Jr.</investigator_full_name>
    <investigator_title>Full Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>lutein</keyword>
  <keyword>zeaxanthin</keyword>
  <keyword>trypan blue</keyword>
  <keyword>dye</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diminazene aceturate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

